Literature DB >> 35032304

Echocardiographic imaging of temporary percutaneous mechanical circulatory support devices.

Tomio Tran1, Parvathi Mudigonda2, Claudius Mahr2, James Kirkpatrick2.   

Abstract

Cardiogenic shock is a state of end-organ hypoperfusion due to primary cardiac dysfunction and portends a poor prognosis. Shock refractory to inotropic and vasopressor support is often an indication for mechanical circulatory support. When mechanical support device complications or malfunction arise, echocardiography offers rapid assessment of device position and function. Repositioning can be done under echocardiographic guidance. Despite the widespread use of percutaneous mechanical circulatory support, there is a dearth of information regarding echocardiography as it pertains to these devices. In this review, we discuss the utility of echocardiography with percutaneous mechanical circulatory support devices.
© 2022. Japanese Society of Echocardiography.

Entities:  

Keywords:  Cardiogenic shock; Mechanical circulatory support; Ventricular assist device

Mesh:

Year:  2022        PMID: 35032304     DOI: 10.1007/s12574-022-00563-y

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  20 in total

1.  Impella 5.0 Mechanical Assist Device Catheter-Induced Severe Hemolysis Due to Giant Swinging Motion - New Concern in Impella Usage.

Authors:  Yasuhisa Nakao; Jun Aono; Tatsuro Tasaka; Teruyoshi Uetani; Haruhiko Higashi; Shuntaro Ikeda; Toshihiro Yorozuya; Hironori Izutani; Osamu Yamaguchi
Journal:  Circ J       Date:  2019-03-21       Impact factor: 2.993

Review 2.  Valvular complications following the Impella device implantation.

Authors:  Davorin Sef; Tito Kabir; Nicholas James Lees; Ulrich Stock
Journal:  J Card Surg       Date:  2021-01-06       Impact factor: 1.620

Review 3.  Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock.

Authors:  Aditya Mandawat; Sunil V Rao
Journal:  Circ Cardiovasc Interv       Date:  2017-05       Impact factor: 6.546

4.  Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock.

Authors:  Mahek Shah; Brijesh Patel; Byomesh Tripathi; Manyoo Agarwal; Soumya Patnaik; Pradhum Ram; Shantanu Patil; Jooyoung Shin; Ulrich P Jorde
Journal:  Int J Cardiol       Date:  2018-06-10       Impact factor: 4.164

5.  The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support.

Authors:  Amit P Amin; John A Spertus; Jeptha P Curtis; Nihar Desai; Frederick A Masoudi; Richard G Bach; Christian McNeely; Firas Al-Badarin; John A House; Hemant Kulkarni; Sunil V Rao
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

6.  Perforation of the Anterior Mitral Leaflet After Impella LP 5.0 Therapy in Cardiogenic Shock.

Authors:  Ashkan Eftekhari; Hans Eiskjær; Christian Juhl Terkelsen; Sten Lyager Nielsen; Evald Høj Christiansen; Steen Hvitfeldt Poulsen
Journal:  Am J Cardiol       Date:  2016-02-17       Impact factor: 2.778

7.  Functional mitral stenosis: a rare complication of the Impella assist device.

Authors:  Stefan Toggweiler; Peiman Jamshidi; Paul Erne
Journal:  Eur J Echocardiogr       Date:  2008-03-30

8.  Percutaneous closure of an iatrogenic atrial septal defect.

Authors:  James P Sur; Francis D Pagani; Mauro Moscucci
Journal:  Catheter Cardiovasc Interv       Date:  2009-02-01       Impact factor: 2.692

9.  Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.

Authors:  Dhaval Kolte; Sahil Khera; Wilbert S Aronow; Marjan Mujib; Chandrasekar Palaniswamy; Sachin Sule; Diwakar Jain; William Gotsis; Ali Ahmed; William H Frishman; Gregg C Fonarow
Journal:  J Am Heart Assoc       Date:  2014-01-13       Impact factor: 5.501

10.  New Surgical Circulatory Support System Outcomes.

Authors:  Danny Ramzy; Edward Soltesz; Mark Anderson
Journal:  ASAIO J       Date:  2020-07       Impact factor: 3.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.